Assessment of therapeutic response in patients with metastatic skeletal disease: Suggested modifications for the MDA response classification criteria

British Journal of Cancer

Volumn 103, Issue 6, 2010, Pages 925-926

  Vassiliou, V ^a   Andreopoulos, D ^a  

^a Bank of Cyprus Group Oncology Centre   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE; BONE DENSITY; BONE DISEASES; METASTASIS; PATHOLOGY; RADIOGRAPHY;

BONE DENSITY; BONE DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM METASTASIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956439562     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605825     Document Type: Letter

References (11)

1. Brown AL, Middleton G, Mac Vicar AD, Husband JE (1998) T1-weighted magnetic resonance imaging in breast cancer vertebral metastases: changes on treatment and correlation with response to therapy. Clin Radiol 53: 493-501
2. Chow E, Holden L, Rubenstein J, Christakis M, Sixel K, Vidmar M, Finkelstein J, Hayter C, Loblaw A, Wong R, Szumacher E, Danjoux C (2004) Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy-a feasibility study. Radiother Oncol 70: 291-294
3. Ciray I, Lindman H, Astrom KG, Bergh J, Ahlstrom KH (2001) Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging. Acta Radiol 42: 198-206
4. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22: 2942-2953
5. Hamaoka T, Costelloe CM, Madewell JE, Liu P, Islam R, Theriault RL, Hortobagyi GN, Ueno NT (2010) Tumor response interpretation with new tumor response criteria vs the World Health Organization criteria in patients with bone-only metastatic breast cancer. Br J Cancer 102: 651-657
6. Hayward JL, Carbone P, Heusen JC, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Br J Cancer 35: 292-298
7. Montemuro F, Russo F, Martincich L, Cirillo S, Gatti M, Aglietta M, Regge D (2004) Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy. Acta Radiol 45: 71-74
8. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, Van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216 (Pubitemid 30099779)
9. Vassiliou V, Kalogeropoulou C, Christopoulos C, Solomou E, Leotsinides M, Kardamakis D (2007a) Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment. Int J Radiat Oncol Biol Phys 67: 264-272
10. Vassiliou V, Kalogeropoulou C, Giannopoulou E, Leotsinidis M, Tsota I, Kardamakis D (2007b) A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate. Clin Exp Metastasis 24: 169-178
11. World Health Organization (WHO) (1979) WHO Handbook for Reporting Results of Cancer Treatment. World Health Organization Offset Publication: Geneva (Switzerland)